Texas Health and Safety Code - HEALTH & SAFETY § 439.102. Written Verification Required for Brand Name Insulin Drug Manufacturer

(a) The manufacturer of a brand name insulin prescription drug for which a generic or biosimilar prescription drug is not available and that is included in the Medicaid vendor drug program formulary must submit to the Health and Human Services Commission a written verification stating whether or not the unavailability of the generic or biosimilar prescription drug is the result, wholly or partly, of:

(b) The executive commissioner shall adopt rules prescribing the form and manner for submission of the written verification required under Subsection (a).